Advancing UK regulatory science and innovation in healthcare

Advancing regulatory science, advancing regulatory practice

In an Editorial of Science in 2011, Margaret A. Hamburg, the then Commissioner of the US Food and Drug Administration highlighted that a strong field of regulatory science is required to develop new tools, standards and approaches that efficiently and consistently assess the safety, efficacy and performance of products, and that this field has long been underappreciated and underfunded.1 During...

Advancing a Vision for Regulatory Science Training.

Regulatory science, a complex field which draws on science, law, and policy, is a growing discipline in medical-related applications. Competencies help define both a discipline and the criteria to measure high-quality learning experiences. This paper identifies competencies for regulatory science, how they were developed, and broader recommendations to enhance education and training in this bur...

Advancing FDA's regulatory science through weight of evidence evaluations.

Leadership for Innovation in Healthcare: An Exploration

Although leadership has been studied extensively, most research has focused on the political and military spheres. More recent work has also examined the role of leadership in sectors such as manufacturing and technology, both areas where it is essential to encourage and nurture innovation. Yet, in the health sector, where innovation is now high on the policy agenda in many countries, there is ...

Advancing Science in Europe

Acknowledgments The DEISA Consortium thanks the European Commission for support through contracts FP6-508830 and FP6-031513. The DECI consists of the identifi cation, enabling, deploying and operation of " fl agship " applications in selected areas of science and technology. These leading, ground breaking applications must deal with complex, demanding, innovative simulations that would not be p...